| |
||||
![]() |
||||
![]() |
||||
|
R01 NS35129-03 R01 NS38097-02 The cerebral cortex is the brain structure that defines us as uniquely human, and which is responsible for all of our higher cognitive functions. Hence, essentially all causes of mental retardation have their effects by somehow disrupting the proper function of the cerebral cortex. Disorders that cause mental retardation include a host of different factors, ranging from genetic disorders that disrupt normal cortical development, to neonatal hypoxic-ischemic injury that damage the maturing cortical cells. Recently, the development of the human genome project has allowed the direct identification of increasing numbers of genes that are required for cortical development. While these genes cause mental retardation, study of the biological function of their gene products potentially gives us insight into the normal development and function of the brain as well. Research Description Highlights of Major Accomplishments
Major Results 1. Cell lineage in developing forebrain 2. Molecular genetics of periventricular heterotopia 3. Molecular genetics of neuronal migration 4. Molecular genetics of double cortex syndrome 5. Molecular genetics of an X-linked form of "nonspecific mental retardation" 1. Cell lineage in developing forebrain Since 1995, we have been continuing previous studies of cell lineage in the developing forebrain. We have found that the cortex is composed of two populations of neurons in terms of their clonal origins. Widespread clones, in which sibling neurons are scattered over much of the area of the cortex, generate a surprisingly large proportion of cortical neurons. However, in addition we have found large clusters of clonally related neurons that can be best seen when clones are labeled at very early developmental stages. While the tendency for some progenitor cells to produce large clusters of clonally related progeny is consistent with a possible role for cell lineage in specification of cerebral cortical regions, the widespread clones suggest that not all neurons can be specified by any lineage-based mechanism. 2. Molecular genetics of periventricular heterotopia A major focus of our research in the last 5 years has been on the positional cloning of genes required for normal human cortical development and the biological characterization of their function. We started by studying a congenital human malformation, called periventricular heterotopia, in which a large number of cortical neurons fail to migrate normally and cause epilepsy. We mapped the responsible gene and presented the genetic and biological features of the disorder in 1996. Our mapping of the gene for periventricular heterotopia led to the identification of the responsible gene as filamin 1 in 1998. Filamin 1 is expressed both inside and outside the nervous system, and patients with filamin 1 mutations have not only brain malformations but other non-CNS conditions, such as strokes and vascular disorders consistent with filamin 1's other functions in platelets and vascular endothelial cells. In migrating cortical neurons, filamin 1 provides a potential link between the signaling molecules and the actin cytoskeleton. We are presently characterizing the function of filamin 1 in migrating neurons. 3. Molecular genetics of neuronal migration Parallel to our interests in human genes that regulate neuronal migration to the cerebral cortex, we also studied a mouse mutant with abnormal gait that reflects abnormal cortical neuronal migration (called scrambler). We characterized this mouse in terms of the specific migrational disturbance that affects the cerebral cortex. We also mapped the gene and identified the specific mutation, defining a disruption of a gene called disabled 1. The mouse disabled 1 gene encodes a cytoplasmic phosphoprotein that presumably represents part of a signaling system that steers migrating neurons. This work provided an entry point into the signaling cascade that guides migrating neurons. We are presently studied the signaling cascade in which disabled functions. 4. Molecular genetics of double cortex syndrome While mapping and analyzing the scrambler mouse and the human periventricular heterotopia syndrome, we established another collaboration to map and clone another X-linked gene that causes an inherited human disorder. This second X-linked gene produces profound neuronal migration arrest in the cortex of males, resulting in mental retardation and epilepsy. Affected females show a milder phenotype in which there is a normal cortex and a second, "double cortex" beneath it, formed by the arrested migration of roughly half of the cortical neurons. After mapping the gene, we identified a single gene, encoding a novel cytoplasmic protein (called doublecortin) as mutated in females with double cortex and in males with X-linked lissencephaly. We have also characterized the patterns of mutations in doublecortin that cause disease, and related these to clinical phenotypes. We have carried out further characterization of the doublecortin protein, and found that it serves as a neuron-specific microtubule-associated protein that functions specifically in migrating neurons and controls microtubule structure. 5. Molecular genetics of an X-linked form of "nonspecific mental retardation" Our study of the double cortex locus led to identification of another gene highly expressed in the brain of other human diseases that map to the same chromosomal region. We identified the gene for one of these conditions, called MRX30. MRX means "nonspecific mental retardation" and refers to individuals with no stigmata of a genetic condition, yet who suffer from mental retardation or learning difficulties in an inherited, X-linked fashion. MRX genes have long been sought after, since they are likely to be required for changing neural connections in the brain that underlie learning and memory. The MRX30 encodes p21-activated kinase 3 (PAK3); the PAK kinases are critical to the control of the cytoskeleton in many cell types, as they bind G proteins of the Rho GTPase family.
Publications Eksioglu Y, Scheffer IE, Cardenas P, Knoll J, DiMario F, Ramsby G, Berg M, Kamuro K, Berkovic SF, Duyk GM, Huttenlocher PR, Walsh C. Periventricular heterotopia: an X-linked dominant epilepsy locus causing aberrant cortical development. Neuron 1996; 16:77-87. [cover illustration] Dobyns WB, Andermann E, Andermann F, Czapansky-Beilman D, Dubeau F, Dulac O, Guerrini R, Hirsch B, Ledbetter DB, Lee NS, Motte J, Pinard J-M, Radtke R, Ross ME, Tampieri D, Walsh CA, Truwit CL. X-linked malformations of neuronal migration. Neurology 1996; 47:331-339. Walsh C. Neural development: Identical twins separated at birth? Current Biology 1996; 6:26-28. Reid CB, Walsh CA. Early development of the cerebral cortex. In, Mize RR, Erzurumlu R. eds. Progress in Brain Research, 1996; 108:17-30. Allen KM and Walsh C. Shaking down new epilepsy genes. Nature Medicine 1996; 2:516-518. Gleeson JG and Walsh CA. New genetic insights into cerebral cortical development. In: Galaburda A, Christen Y. eds. Normal and Abnormal Development of the Cerebral Cortex. Berlin: Springer-Verlag, 1997; 145-163. Ross ME, Allen KM, Srivastava AK, Featherstone T, Hirsch B, Harding BN, Abdullah R, Berg ME, Czapansky-Bielman D, Flanders DJ, Gleeson JG, Guerrini R, Motte J, Scheffer I, Berkovic S, King RA, Ledbetter DH, Schlessinger D, Dobyns WB, Walsh CA. Linkage and physical mapping of X-linked lissencephaly/SBH (XLIS): a novel gene causing neuronal migration defects in human brain. Hum Molec Genet 1997; 6:555-563. Reid CB, Tavazoie SF, Walsh CA. Asymmetric division and clonal dispersion in ferret neocortex. Development 1997; 124:2441-2450. Gonzàlez JL, Goldowitz D, Sweet HO, Davisson MT, Walsh CA. Birthdate and cell marker analysis of scrambler: a novel mutation affecting cortical development with a reeler-like phenotype. J Neurosci 1997; 17:9204-9211. Ware ML, Fox JW, Gonzalez JL, Davis NM, Lambert de Rouvroit C, Russo CJ, Chua SC, Jr., Goffinet AM, Walsh, CA. Aberrant splicing of a mouse disabled homologue, mdab1, in the scrambler mouse. Neuron 1997; 19:239-249. Berg MJ, Schifitto G, Powers JM, Martinez-Capolino C, Fong C-T, Myers GJ, Epstein LG, Walsh CA. X-linked female band heterotopia-male lissencephaly syndrome. Neurology 1998; 1143-1146. Gleeson JG, Allen KM, Fox JW, Lamperti ED, Berkovic S, Scheffer I, Dobyns WB, Minnerath SR, Ross ME, Walsh, CA. Doublecortin, a brain-specific gene mutated in human X-linked lissencephaly and double cortex syndrome, encodes a putative signaling protein. Cell 1998; 92:62-73. [cover illustration] Allen KM, Gleeson JG, Shoup SM, Walsh CA. A YAC contig in Xq23, from DXS287 to DXS2088, spanning the critical region for double cortex/X-linked lissencephaly (DC/XLIS). Genomics 1998; 52:214-218. Pilz DT, Matsumoto N, Minnerath S, Mills P, Gleeson JG, Allen KM, Walsh CA, Barkovich AJ, Dobyns WB, Ledbetter DH, Ross ME. LIS1 and XLIS (DCX) mutations cause most classical lissencephaly, but different patterns of malformation. Hum Molec Genet 1998; 7:2029-2037. Allen KM, Gleeson JG, Partington MW, MacMillan JC, Mulley JC, Walsh CA. Mutation in the PAK3 gene in nonsyndromic X-linked mental retardation. Nature Genetics 1998; 20:25-31. Fox JW, Lamperti ED, Eksioglu YZ, Hong SE, Feng Y, Graham DA, Scheffer IE, Dobyns WB, Hirsch BA, Radtke RA, Berkovic SF, Huttenlocher PR, Walsh CA. Mutations in Filamin 1 arrest migration of cerebral cortical neurons in human periventricular heterotopia. Neuron 1998; 21:1315-1325 [cover illustration]. Walsh, CA. LISsen Up! Nature Genetics 1998; 19:307-308. Walsh CA. Cell lineage analysis in the central nervous system. Encyclopedia of Neuroscience, Berlin: Elsevier Press, 1998. Walsh C. Early events in the development of the cerebral cortex. In: Engel J, Pedley TA. eds. Epilepsy: A Comprehensive Textbook, 2nd edition and CD-ROM edition. NY: Lippincott-Raven Publishers, 1998. Ware ML and Walsh CA. Cell lineage and cell migration in the developing cerebral cortex. In: Moody SA. ed. Cell Fate and Cell Fate Determination. NY: Academic Press, 1999; 529-547. Walsh, CA. Genetic malformations of the human cerebral cortex. Neuron 1999; 23:19-29. Fox JW and Walsh CA. Periventricular heterotopia and the genetic control of neuronal migration. Am J Hum Genet 1999; 65:19-24. Reid CB, Liang I, Walsh, CA. Clonal mixing, clonal restriction, and specification of cell types in the developing rat olfactory bulb. J Comp Neurol 1999; 403:106-118. Gleeson JG, Minnerath SR, Allen KM, Fox JW, Hong SE, Berg MJ, Kuzniecky R, Reitnauer PJ, Borgatti R, Mira AP, Guerrini R, Holmes GL, Rooney CM, Berkovic S, Scheffer I, Cooper EC, Leroy R, Andermann E, Wheless JW, Dobyns WB, Ross ME, Walsh CA. Characterization of mutations in the gene doublecortin in patients with double cortex syndrome. Ann Neurol 1999; 45:146-53. Ware ML, Tavasoie S, Reid CB, Walsh CA. Coexistence of widespread clones and large radial clonal patterns in early ferret cortex. Cerebral Cortex 1999; 9:636-645. Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999; 23:257-271. Dobyns WB, Truwit CL, Ross ME, Matsumoto N, Pilz DT, Ledbetter DH, Gleeson JG, Walsh CA, Barkovich AJ. Differences in gyral pattern distinguish chromosome 17-linked lissencephaly and X-linked lissencephaly. Neurology 1999; 53:270-277. Chenn A, Walsh CA. Perspectives: neurobiology. Cranking it up a notch. Science 1999; 286:689-690. Allen KM, Walsh CA. Genes that regulate neuronal migration in the cerebral cortex. Epilepsy Research 1999; 36:143-154. Walsh CA. Genetics of neuronal migration in the cerebral cortex. MRDD Res Rev 2000: 6:34-40. Feng Y, Olson EC,
Stukenberg PT, Flanagan LA, Kirschner MW, Walsh CA. LIS1 regulates CNS
lamination by interacting with mNudE, a central component of the centrosome.
Neuron 2000; 28:665-679. Walsh CA, Goffinet AM. Potential mechanisms of mutations that affect neuronal migration in man and mouse. Curr Opin Genet Dev 2000; 10:270-274. Taylor KR, Holzer
AK, Bazan JF, Walsh CA, Gleeson JG. Patient mutations in doublecortin
define a repeated tubulin-binding domain. J Biol Chem 2000;275(44):34442-50.
See Dr. Walsh's publications via PubMed Contact Information E-mail:
Christopher Walsh, MD/PhD Lab
Members:
|
|||